Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
EmailIphone Application    Posted: 7th August 2012
If you would like to forward this story on to a friend, simply fill in the form below and click send.
Your friend's email:
Your email:
Your name:
 
 
Send Cancel
Atypical myopathy case studies
BEVA is publishing new information on atypical myopathy

New information on the atypical myopathy (AM) disease, affecting grazing horses, is to be published, following 600 case studies.

Between 2006 and 2009, Dr Gaby Van Galen and her colleagues studied cases reported to the Atypical Myopathy Alert Group across Europe. Their findings are to be published in the next issue of Equine Veterinary Journal by the British Equine Veterinary Association (BEVA).

Out of 600 reported AM cases, 354 were identified. Overall survival of the disease is a low 26 percent, with successful cases including those that remained standing and antioxidant therapy.

It is not yet known what causes the disease, which has been recognised since 1984 and appears during the spring and/or autumn; however, risk factors include the presence of dead leaves, sloping pastures and full-time pasture access, to name a few.

Become a member or log in to add this story to your CPD history

Defra shares new Sanitary and Phytosanitary guidance

News Story 1
 Defra has published guidance for the vet sector ahead of a proposed UK-EU Sanitary and Phytosanitary agreement.

The agreement, which will change the movement and trade of animals and related products, could see reductions in checks, paperwork and certification. As well as describing regulatory developments, the advice highlights the importance of animal ID, registration and traceability in disease control and other compliance arrangements.

The guidance can be found here. More detail is expected as negotiations progress. 

Click here for more...
News Shorts
Lords Committee opens Pet Parasite Medication inquiry

The House of Lords Environment and Climate Change Committee will launch its inquiry into Pet Parasite Medication (PPM) on Wednesday (3 June).

Focusing on treatments containing fipronil and imidacloprid, the inquiry will seek to understand distribution pathways and the impacts of PPM use and non-use on biodiversity and human health. It will also cover current regulation, monitoring, and the potential implications for pets and their owners.

The committee will hear evidence from environmental non-governmental organisations and research institutes. The public can follow the proceedings live on Parliament TV or in person in the Palace of Westminster.